The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells

Despite maximally safe resection of the magnetic resonance imaging (MRI)–defined contrast-enhanced (CE) central tumor area and chemoradiotherapy, most patients with glioblastoma (GBM) relapse within a year in peritumoral FLAIR regions. Magnetic resonance spectroscopy imaging (MRSI) can discriminate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemarié, Anthony, Lubrano, Vincent, Delmas, Caroline, Lusque, Amélie, Cerapio, Juan-Pablo, Perrier, Marion, Siegfried, Aurore, Arnauduc, Florent, Nicaise, Yvan, Dahan, Perrine, Filleron, Thomas, Mounier, Muriel, Toulas, Christine, Cohen-Jonathan Moyal, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624352/
https://www.ncbi.nlm.nih.gov/pubmed/37922359
http://dx.doi.org/10.1126/sciadv.adi0114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624352/
https://www.ncbi.nlm.nih.gov/pubmed/37922359
http://dx.doi.org/10.1126/sciadv.adi0114

Ejemplares similares